[ Price : $8.95]
FDA begins enforcement actions against companies illegally marketing breast binders to children, placing the agencys role at the c...[ Price : $8.95]
During recent drug user fee negotiations on reauthorizing the PDUFA program, FDA officials and pharmaceutical industry representat...[ Price : $8.95]
FDA approves a new subcutaneous formulation of Johnson & Johnsons lung cancer drug amivantamab, allowing the therapy to be adminis...[ Price : $8.95]
Regulators place a clinical hold on a pivotal lung cancer trial of ifinatamab deruxtecan after reports of treatment-related deaths...[ Price : $8.95]
House and Senate Democratic health leaders ask AstraZeneca, Lilly, Novo Nordisk, and Pfizer for details about the drug pricing dea...[ Price : $8.95]
FDA issues a Warning Letter to Catalents Bloomington, IN, drug manufacturing plant, citing significant manufacturing violations af...[ Price : $8.95]
Diamond Research Foundation founder Beth Rosenshein petitions FDA to update Premarin labeling with information on the estrogen hor...[ Price : $8.95]
Two Mintz attorneys urge stakeholders to monitor FDA communications involving compliance and review carefully, looking for issues ...